主题词1:incidence
排序:最新发表
Clear All
Effects of dezocine with ropivacaine on epidural analgesia during labor: a randomized controlled trial [0.03%]
Bin Su,Panlian Qian,W P Zhang et al. Bin Su et al.
Results: The incidence of itching was lower in the group D than the control group (0% vs. 10%, P = 0.036)....Conclusion: This study indicated that the epidural use of dezocine increased the analgesic effect, prolonged the duration of analgesia and decreased the incidence of itching during labor without increasing adverse events of mothers and neonates.
Resveratrol and N-acetylcystein reduce hepatic steatosis but enhance initiation and progression of hepatocellular carcinoma by inhibiting GST-pi-MAPK axis in mice [0.03%]
Mi Zhang,Weigang Yuan,Chun Li et al. Mi Zhang et al.
Conclusion: Antioxidants may increase the incidence of HCC in a population with fatty liver, despite reduction in ROS production, by inhibiting GST-pi-MAPK axis.
The role of hepatic sinusoidal microenvironment in NASH: pathogenesis, animal models, and therapeutic prospects [0.03%]
Wanying Tan,Jiangting Deng,Lingjun Qi et al. Wanying Tan et al.
The incidence of nonalcoholic steatohepatitis (NASH) is increasing annually, posing a significant threat to human health. NASH is typified by hepatic steatosis, inflammation, and hepatocellular injury, frequently culminating in fibrosis and cirrhosis.
Q14.42024 Review Frontiers in pharmacology. 2025 Apr 28:16:1467950. DOI:10.3389/fphar.2025.1467950 2025
Qi-Long Mao,Zi-Hang Yu,Liang Nie et al. Qi-Long Mao et al.
Both preclinical and clinical research have demonstrated the incidence of gastrointestinal injuries following CPB, often accompanied by dysbiosis and abnormal metabolic outputs. Currently, interventions addressing gastrointestinal injuries following CPB remain insufficient.
Q14.42024 Review Frontiers in pharmacology. 2025 Apr 28:16:1542995. DOI:10.3389/fphar.2025.1542995 2025
Incidence of infection associated with eculizumab: a meta-analysis of 9 randomized controlled trials [0.03%]
Aidou Jiang,Ying Liu,Chunyan Wei et al. Aidou Jiang et al.
Background and aims: Eculizumab is expected to lead to increased susceptibility to infection. We performed a meta-analysis of data from randomized controlled trials (RCTs) to determine the risk of infection in eculizumab-...
The administration sequences of immune checkpoint inhibitors and chemotherapy cause discrete efficacy when treating non-small cell lung cancer: a retrospective study [0.03%]
Bicheng Zhang,Yuxiao Song,Qian Min et al. Bicheng Zhang et al.
The incidence of TRAEs of any grade in the concurrent, the immune-chemo, and the chemo-immune groups was 77.52% (100/129), 65.67% (44/67), and 59.46% (44/74) rates, respectively, which was a significant difference (χ²=7.91, P=0.019).
Q15.72024 Multicenter Study Frontiers in immunology. 2025 Apr 28:16:1579420. DOI:10.3389/fimmu.2025.1579420 2025
Impact of prophylactic cytomegalovirus immunoglobulin on cytomegalovirus viremia and graft function in ABO-incompatible living donor kidney transplantation: a retrospective analysis [0.03%]
Linhong Zhong,Shijie Tang,Zhongping Pu et al. Linhong Zhong et al.
The primary outcome was measured as the incidence of clinically relevant CMV viremia (CMV DNA >10,000 copies/mL) within one year after transplantation....Results: Prophylactic CMV immunoglobulin significantly reduced clinically relevant viremia incidence compared to preemptive therapy group (16.0% vs. 34.0%, P = 0.04)....Conclusion: CMV immunoglobulin represents a promising prophylactic option for reducing clinically relevant CMV viremia incidence and delaying infection onset in ABO-incompatible kidney transplant recipients.
Crosstalk between the tumor immune microenvironment and metabolic reprogramming in pancreatic cancer: new frontiers in immunotherapy [0.03%]
Jintai Shi,Xiaoyan Cui,Junlin Wang et al. Jintai Shi et al.
In recent years, the incidence and mortality of pancreatic cancer (PC) are increasing year by year. The highly heterogeneous nature of PC, its strong immune escape ability and easy metastasis make it the most lethal malignant tumor in the world.
Q15.72024 Review Frontiers in immunology. 2025 Apr 28:16:1564603. DOI:10.3389/fimmu.2025.1564603 2025
Clinical manifestations and risk factors of immune-related thyroid adverse events in patients treated with PD-1 inhibitors: a case-control study [0.03%]
Pengfei Zhao,Jia Li,Lihong Yu et al. Pengfei Zhao et al.
The overall incidence of thyroid dysfunction was 2.97%, with hypothyroidism occurring in 1.20%, hyperthyroidism in 1.77%, and thyroiditis in 0.50% of patients. Tislelizumab exhibited the highest incidence at 3.48%, followed by camrelizumab at 3.10%, sintilimab at 2.24%, and toripalimab at 1.75%.
Vitamin D receptor gene polymorphism in oral cancer as a function of tobacco consumption: an evidence based systematic review and meta-analysis [0.03%]
Tribikram Debata,Amrita Swain,Soumya Ranjan Jena et al. Tribikram Debata et al.
The incidence was evaluated as an odds ratio (OR) with 95% confidence interval (95% CI) using SPSS software.
耗时 0.22756 秒,为您在
48064620
条记录里面共找到 10000 篇文章 [XML]